Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Enrolled In The AIEOP AML 2002/01 Trial: The Impact Of Minimal Residual Disease On Patient Outcome

Martina Pigazzi, Ph.D., Valzerda Beqiri, MD, Elena Manara, PhD, Roberto Rondelli, Riccardo Masetti, MD, Carmelo Rizzari, MD, PhD, Maria Caterina Putti, Andrea Pession, Franco Locatelli, Giuseppe Basso, MD

Blood (2013) 122 (21): 3884.

https://doi.org/10.1182/blood.V122.21.3884.3884

Published: 2013

Journal Articles

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

David Guenat, Carmelo Rizzari, MD, PhD, Patrick Edery, MD, PhD, Jean Soulier, MD, PhD, Christophe Ferrand, PhD, Christophe Borg, MD, PhD, Pierre-Simon Rohrlich, MD, PhD

Blood (2013) 122 (21): 4898.

https://doi.org/10.1182/blood.V122.21.4898.4898

Published: 2013

Journal Articles

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Riccardo Masetti, MD, Martina Pigazzi, PhD, Andrea Pession, Prof, MD, Carmelo Rizzari, MD, PhD, Nicola Santoro, Luca lo Nigro, Matteo Luciani, Giuseppe Menna, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2012) 120 (21): 3585.

https://doi.org/10.1182/blood.V120.21.3585.3585

Published: 2012

Journal Articles

Favorable Outcome of Children with Acute Megakaryoblastic Leukemia Treated with the AIEOP AML 2002/01 Protocol

Franco Locatelli, Maria Caterina Putti, Andrea Pession, Prof, MD, Franca Fagioli, MD, Giuseppe Menna, Concetta Micalizzi, Carmelo Rizzari, MD, PhD, Sergio Rutella, MD PhD, Andrea Biondi, MD, Barbara Buldini, Riccardo Masetti, MD, Giuseppe Basso

Blood (2012) 120 (21): 3586.

https://doi.org/10.1182/blood.V120.21.3586.3586

Published: 2012

Journal Articles

Frequency and Prognostic Relevance of Gene Mutations in Pediatric AML Patients At First Relapse.

Costa Bachas, MSc, Gerrit Jan Schuurhuis, PhD, Dirk Reinhardt, MD, Ursula Creutzig, MD, PhD, Zinia J. Kwidama, BSc, C. Michel Zwaan, MD, PhD, Marry M. van den Heuvel-Eibrink, Evelina S De Bont, MD, PhD, Sara Elitzur, MD, Carmelo Rizzari, MD, PhD, Valérie de Haas, MD, PhD, Martin Zimmermann, Jacqueline Cloos, PhD, Gertjan J.L. Kaspers, MD, PhD

Blood (2012) 120 (21): 2480.

https://doi.org/10.1182/blood.V120.21.2480.2480

Published: 2012

NARROW

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Enrolled In The AIEOP AML 2002/01 Trial: The Impact Of Minimal Residual Disease On Patient Outcome

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Favorable Outcome of Children with Acute Megakaryoblastic Leukemia Treated with the AIEOP AML 2002/01 Protocol

Frequency and Prognostic Relevance of Gene Mutations in Pediatric AML Patients At First Relapse.

Email alerts

ASH Publications

American Society of Hematology

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Enrolled In The AIEOP AML 2002/01 Trial: The Impact Of Minimal Residual Disease On Patient Outcome

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Favorable Outcome of Children with Acute Megakaryoblastic Leukemia Treated with the AIEOP AML 2002/01 Protocol

Frequency and Prognostic Relevance of Gene Mutations in Pediatric AML Patients At First Relapse.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only